Startseite > Produktkatalog > Biowissenschaften > Nukleosid > α-L-Talofuranuronic acid, 1-deoxy-5-O-[2,3-di-O-benzoyl-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, methyl ester, 2-benzoate (9CI)
[CAS No.360772-38-9] A1255151 α-L-Talofuranuronic acid, 1-deoxy-5-O-[2,3-di-O-benzoyl-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, methyl ester, 2-benzoate (9CI) 97%
Katalognummer:
Cas No.:
Summenformel:
Molekulargewicht:
MDL No:
EINECS:
Bestellung/Angebotsanfrage/Technischer Support
Telefon: 0086-571-89925085
bestellen & Anfrage: sales@amadischem.com
technischer Support: tech@amadischem.com
*Alle Chemikalien unseres Unternehmens sind nur für den Labor- und Produktionsgebrauch bestimmt.
Qualitätskontrolle [360772-38-9]

NMR

CNMR

HPLC

LC-MS

zugehörige Dokumente [360772-38-9]
Basisinformationen [360772-38-9]
Synonyme:
Aussehen:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Lageranforderungen:
Pubchem ID:
Smiles:
Inchi:
InchiKey:
Sicherheitsinformationen [360772-38-9]
Piktogramm:
Signalwort:
UN No.:
Gefahrenkategorie:
Verpackungsklasse:
Gefahrenhinweise:
Sicherheitshinweise:
Verwandte Literatur [360772-38-9]
Es tut uns leid, keine entsprechende Literatur
Ähnliche Produkte [360772-38-9]
α-L-Talofuranuronamide, 1-deoxy-5-O-[2,3-di-O-benzoyl-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-benzoate (9CI)
Reason:Nukleosid
α-L-Talofuranuronamide, 1-deoxy-5-O-[2,3-di-O-acetyl-4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-acetate (ACI)
Reason:Nukleosid
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-heptadecanoate (9CI)
Reason:Nukleosid
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-2,3-O-(1-methylethylidene)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-[3,4-dihydro-3-[[(4-methoxyphenyl)methoxy]methyl]-2,4-dioxo-1(2H)-pyrimidinyl]-2-O-hexyl-3-O-methyl- (9CI)
Reason:Nukleosid
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-2,3-O-(1-methylethylidene)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-[3,4-dihydro-3-[[(4-methoxyphenyl)methoxy]methyl]-2,4-dioxo-1(2H)-pyrimidinyl]-3-O-methyl- (9CI)
Reason:Nukleosid
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-3-O-(1-oxohexadecyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
Reason:Nukleosid
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-3-O-(1-oxopentadecyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
Reason:Nukleosid
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-3-O-(1-oxotetradecyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
Reason:Nukleosid
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-3-O-(1-oxododecyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
Reason:Nukleosid
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-3-O-(1-oxodecyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
Reason:Nukleosid
Produktdetails [360772-38-9]
Es tut uns leid, keine Produktdetails verfügbar
Browserverlauf
wettbewerbsfähige Preise
effiziente Logistik
technischer Support
ausreichende Lagerbestände